Literature DB >> 33156230

Measuring Bone Loss in the Unstable Shoulder: Understanding and Applying the Track Concept.

Giovanni Di Giacomo1, Nicola de Gasperis.   

Abstract

An interesting international debate has been developed over the past 10 years (the last decade) surrounding the surgical procedure for recurrent anteroinferior instability and a definitive consensus is lacking on the factors which favor one technique over another, especially when bone loss is present (soft tissue vs. bone block). Glenoid bone loss is commonly observed in the shoulder with anterior instability, and it is difficult to evaluate the shape of the glenoid using plain radiograph, therefore, computed tomography or intraoperative observation is recommended for accurate assessment of glenoid bone loss and Hill-Sachs lesion. When we consider the bony defect of the glenoid as a risk factor for surgical failure, it is crucial to take into consideration the features of a concomitant Hill-Sachs lesion. However, all the previous reports focusing on the size of the Hill-Sachs lesion or on the glenoid bone loss in isolation, overlook the interaction of the 2 lesions through the arc of range of motion and how this may influence instability. The glenoid track is the first model to determine, in a dynamic way, how bone loss on both sides of the joint can lead to instability. The glenoid track is a zone of contact created by the glenoid on the humeral articular surface when the arm is moved along the end-range of motion (abduction and external rotation). The use of the glenoid track concept can potentially help guide surgical decision-making.

Entities:  

Mesh:

Year:  2020        PMID: 33156230     DOI: 10.1097/JSA.0000000000000293

Source DB:  PubMed          Journal:  Sports Med Arthrosc Rev        ISSN: 1062-8592            Impact factor:   1.985


  1 in total

Review 1.  Assessing Bone Loss in the Unstable Shoulder: a Scoping Review.

Authors:  Kyle Gouveia; Syed Fayyaz H Rizvi; Danielle Dagher; Timothy Leroux; Asheesh Bedi; Moin Khan
Journal:  Curr Rev Musculoskelet Med       Date:  2022-07-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.